SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-008087
Filing Date
2018-11-21
Accepted
2018-11-21 06:30:17
Documents
2
Period of Report
2018-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_112118.htm 6-K 5336
2 PRESS RELEASE exh_991.htm EX-99.1 2773
  Complete submission text file 0001171843-18-008087.txt   9159
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 181196982
SIC: 2834 Pharmaceutical Preparations